THERMO FISHER SCIENTIFIC INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Thermo Fisher Scientific Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q2 2024.
  • Thermo Fisher Scientific Inc. Operating Income (Loss) for the quarter ending June 29, 2024 was $1.82B, a 15.3% increase year-over-year.
  • Thermo Fisher Scientific Inc. Operating Income (Loss) for the twelve months ending June 29, 2024 was $7.2B, a 7.29% increase year-over-year.
  • Thermo Fisher Scientific Inc. annual Operating Income (Loss) for 2023 was $6.86B, a 18.3% decline from 2022.
  • Thermo Fisher Scientific Inc. annual Operating Income (Loss) for 2022 was $8.39B, a 16.3% decline from 2021.
  • Thermo Fisher Scientific Inc. annual Operating Income (Loss) for 2021 was $10B, a 28.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.2B $1.82B +$242M +15.3% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-02
Q1 2024 $6.96B $1.66B +$100M +6.4% Jan 1, 2024 Mar 30, 2024 10-Q 2024-05-03
Q4 2023 $6.86B $1.85B -$7M -0.38% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $6.87B $1.86B +$154M +9.01% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $6.71B $1.58B -$423M -21.1% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-02
Q1 2023 $7.14B $1.56B -$1.26B -44.6% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-03
Q4 2022 $8.39B $1.86B -$677M -26.7% Oct 2, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $9.07B $1.71B -$568M -24.9% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-03
Q2 2022 $9.64B $2B -$162M -7.49% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-04
Q1 2022 $9.8B $2.82B -$228M -7.48% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-05
Q4 2021 $10B $2.54B -$533M -17.4% Oct 3, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $10.6B $2.28B -$148M -6.1% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-04
Q2 2021 $10.7B $2.16B +$772M +55.5% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-05
Q1 2021 $9.94B $3.05B +$2.14B +237% Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-06
Q4 2020 $7.79B $3.07B +$1.84B +149% Sep 27, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $5.96B $2.43B +$1.48B +156% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-04
Q2 2020 $4.48B $1.39B -$105M -7.02% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-06
Q1 2020 $4.58B $906M -$14M -1.52% Jan 1, 2020 Mar 28, 2020 10-Q 2021-05-07
Q4 2019 $4.59B $1.23B +$84M +7.32% Sep 29, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $4.51B $946M +$34M +3.73% Jun 30, 2019 Sep 28, 2019 10-Q 2020-10-30
Q2 2019 $4.48B $1.5B +$559M +59.7% Mar 31, 2019 Jun 29, 2019 10-Q 2020-07-31
Q1 2019 $3.92B $920M +$134M +17% Jan 1, 2019 Mar 30, 2019 10-Q 2020-05-01
Q4 2018 $3.78B $1.15B +$191M +20% Sep 30, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $3.59B $912M +$278M +43.8% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-01
Q2 2018 $3.31B $937M +$188M +25.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $3.13B $786M +$166M +26.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $2.96B $957M +$196M +25.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $2.76B $634M +$92.9M +17.2% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $2.67B $749M +$111M +17.5% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-03
Q1 2017 $2.56B $620M +$102M +19.7% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-04
Q4 2016 $2.46B $761M +$71.4M +10.3% Oct 2, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $2.39B $541M -$21.8M -3.87% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-03
Q2 2016 $2.41B $638M +$41.8M +7.02% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-04
Q1 2016 $2.37B $518M +$30.6M +6.28% Jan 1, 2016 Apr 2, 2016 10-Q 2017-05-05
Q4 2015 $2.34B $690M +$50.9M +7.96% Sep 27, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $2.29B $563M -$77.4M -12.1% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-04
Q2 2015 $2.36B $596M +$248M +71.2% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-05
Q1 2015 $2.11B $487M -$388M -44.3% Jan 1, 2015 Mar 28, 2015 10-Q 2016-05-06
Q4 2014 $2.5B $639M +$184M +40.5% Sep 28, 2014 Dec 31, 2014 8-K 2017-05-05
Q3 2014 $2.32B $640M +$248M +63.3% Jun 29, 2014 Sep 27, 2014 10-Q 2015-10-30
Q2 2014 $2.07B $348M -$27.3M -7.27% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-31
Q1 2014 $2.1B $876M +$488M +126% Jan 1, 2014 Mar 29, 2014 10-Q 2015-05-01
Q4 2013 $1.61B $455M +$54.4M +13.6% Sep 29, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $1.56B $392M +$39.9M +11.3% Jun 30, 2013 Sep 28, 2013 10-Q 2014-10-31
Q2 2013 $1.52B $375M +$7.6M +2.07% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-01
Q1 2013 $1.51B $387M +$25.6M +7.08% Jan 1, 2013 Mar 30, 2013 10-Q 2014-05-02
Q4 2012 $1.48B $401M +$52.4M +15% Sep 30, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $1.43B $352M +$36.2M +11.5% Jul 1, 2012 Sep 29, 2012 10-Q 2013-11-01
Q2 2012 $1.39B $368M +$103M +38.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $1.29B $362M +$40M +12.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $1.25B $348M +$45.3M +15% Oct 2, 2011 Dec 31, 2011 8-K 2014-05-02
Q3 2011 $1.21B $316M +$13.3M +4.39% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-02
Q2 2011 $1.19B $265M -$32.8M -11% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-03
Q1 2011 $1.23B $322M +$36.9M +13% Jan 1, 2011 Apr 2, 2011 10-Q 2012-05-04
Q4 2010 $1.19B $303M Oct 3, 2010 Dec 31, 2010 8-K 2013-05-03
Q3 2010 $303M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-04
Q2 2010 $298M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-05
Q1 2010 $285M Jan 1, 2010 Apr 3, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.